Lutein in Diabetes and Diabetic Kidney Disease: From Oxidative Stress Modulator to Clinical Biomarker

Authors

  • Hamed Abdelaziz Deraz Nasr, Atef Goda Hussein, Sara Ibrahem Mohamed Selim, Elshabrawy Mohamed Mahmoud Abdelnaby

Keywords:

Lutein, Diabetes, Diabetic Kidney Disease

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder marked by insulin resistance,hyperglycemia, and significant long-term complications, including diabetic kidney disease (DKD). Both conditionsrepresent a growing global health concern, particularly in the elderly, with projections indicating a substantial

References

Patil S, Gothwal S, Ahmed MS, et al. A comprehensive review on diabetes mellitus: molecular mechanisms and recent therapeutic advancements. Biomed Pharmacother 2023; 164:114922.

Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020; 21(17):6275.

Downloads

Published

2024-06-20

How to Cite

Hamed Abdelaziz Deraz Nasr, Atef Goda Hussein, Sara Ibrahem Mohamed Selim, Elshabrawy Mohamed Mahmoud Abdelnaby. (2024). Lutein in Diabetes and Diabetic Kidney Disease: From Oxidative Stress Modulator to Clinical Biomarker . Journal of Computational Analysis and Applications (JoCAAA), 33(06), 2470–2479. Retrieved from https://eudoxuspress.com/index.php/pub/article/view/3411

Issue

Vol. 33 No. 06 (2024): JOCAAA

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.